CSF3 and neutropenia: The LEARN I study, conducted in 2003, was a multicentre, retrospective, observational study in Spain comparing patterns of use of daily G-CSF and pegfilgrastim, and neutropenia-related outcomes in adults with non-myeloid malignancies receiving myelosuppressive chemotherapy (Almenar et al. 2009).